SCHEMBL2113279

SCHEMBL2113279

CN(C)CCc1cnc(Nc2cccc(F)c2F)nc1N

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 1/20 0.43
NOS3 P29474 1/20 0.37
NOS1 P29475 1/20 0.37
NOS2 P35228 1/20 0.37
CDK9 P50750 3/20 0.37
CCNT1 O60563 2/20 0.37
HTR2A P28223 1/20 0.36
HTR2C P28335 1/20 0.36
HTR2B P41595 1/20 0.36
AOC3 Q16853 1/20 0.36
CNR2 P34972 1/20 0.36
ULK1 O75385 1/20 0.35
BCDIN3D Q7Z5W3 1/20 0.34
JAK2 O60674 2/20 0.34
JAK1 P23458 2/20 0.34
JAK3 P52333 2/20 0.34
CDK2 P24941 2/20 0.34
CCNA2 P20248 1/20 0.34
CCNA1 P78396 1/20 0.34
INSR P06213 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2113372 0.93 NOS1 (0.37) TAAR1NOS3NOS1NOS2CDK9
SCHEMBL2112982 0.92 JAK2 (0.35) TAAR1NOS3NOS1NOS2CDK9
SCHEMBL2114796 0.91 TAAR1 (0.49) TAAR1AOC3CDK2CCNA2CCNA1
SCHEMBL2117595 0.87 TAAR1 (0.47) TAAR1NOS3NOS1NOS2CDK9
SCHEMBL5530876 0.84 CNR2 (0.34) CDK9CNR2ULK1BCDIN3DCDK2
SCHEMBL2113341 0.84 TAAR1 (0.40) TAAR1NOS1AOC3CDK2POLB
SCHEMBL2115239 0.83 TAAR1 (0.40) TAAR1CDK2POLBMAPT
SCHEMBL2113990 0.82 HTT (0.44) JAK2CDK2CCNA2INSRALK
SCHEMBL2114996 0.82 HTT (0.49) CDK9CDK2CCNA2INSRALK
SCHEMBL2114730 0.81 DHFR (0.42) TAAR1CDK9CCNT1BCDIN3DJAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8158641-B2 2-anilino-4-aminoalkyleneaminopyrimidines BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-04-17 US disclosed
US-20090181995-A1 2-ANILINO-4-AMINOALKYLENEAMINOPYRIMIDINES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-07-16 US disclosed
US-20070293525-A1 2-ANILINO-4-AMINOALKYLENEAMINOPYRIMIDINES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-12-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070293525-A1 2-ANILINO-4-AMINOALKYLENEAMINOPYRIMIDINES PRKCA, PRKCH, PRKCG TAAR1 3765/4885NOS3 635/4885NOS1 643/4885
US-20090181995-A1 2-ANILINO-4-AMINOALKYLENEAMINOPYRIMIDINES PRKCA, PRKCH, PRKCG TAAR1 3765/4885NOS3 635/4885NOS1 643/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.